Thursday, 5 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Merger & Restructuring

Rubicon Research Merger & Restructuring Worth ₹27.84 Cr

Rubicon Research Limited's subsidiary acquired a manufacturing facility in New Jersey, USA, from InvaTech Pharma Solutions, LLC for an enterprise value of ₹27.84 Crore.

Key figures
Value₹27.84 Cr
Source

NSE filing, NSE: RUBICON. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Rubicon Research Ltd: key numbers

Share price
₹1,740.00
Market cap
₹28,803 Cr
Revenue (annual)
₹1,754 Cr
Net profit (annual)
₹246.7 Cr
P/E (TTM)
99.9×Sector 37.9×
Promoter holding
51.25%-8.51% QoQ
FII holding
9.01%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Rubicon Research Ltd

All →

Other merger & restructuring announcements

All →